| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Forte Biosciences, Inc. (FBRX) has 8 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. FBRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 500.0K | $8.93M | - | |
| CFO | 22.0K | $392.7K | - | |
| Dir | 18.4K | $327.6K | - | |
| Dir | 18.4K | $327.6K | - | |
| Dir | 18.4K | $327.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2020 | Riley Antony A65 | Chief Financial Officer | Buy | 6,700 | $14.39 | $96,445.20 | +10.6% | |
| Jun 25, 2020 | Wagner Paul A.76 | See Remarks | Buy | 7,000 | $14.48 | $101,355.80 | +0.3% | |
| Apr 14, 2020 | Oliveira Steven Michael | 10% Owner | Buy | 74,301 | $1.19 | $88,418.19 | +2.7% | |
| Mar 2, 2020 | Oliveira Steven Michael | 10% Owner | Buy | 65,149 | $1.35 | $87,755.70 | +2.4% | |
| May 30, 2019 | Hasnain Faheem74 | Director | Buy | 43,000 | $4.66 | $200,314.52 | +6.2% | |
| May 28, 2019 | Foletta Mark G72 | EVP &Chief Financial Officer | Buy | 5,000 | $4.30 | $21,475.00 | +49.8% | |
| May 28, 2019 | Duvall Martin J | Chief Executive Officer | Buy | 5,000 | $4.34 | $21,678.50 | +58.1% | |
| May 24, 2019 | Gruber Harry E | President, Science&Innovation | Buy | 5,000 | $4.56 | $22,782.50 | +105.4% | |
| Apr 19, 2017 | Schimmel Paul53 | Director | Buy | 10,000 | $10.00 | $100,000.00 | +276.0% | |
| Apr 19, 2017 | Das Asha | SVP &Chief Medical Officer | Buy | 2,500 | $10.00 | $25,000.00 | New |